Literature DB >> 26239608

Transplantation: Sustained benefits of islet transplants for T1DM.

Bernhard J Hering1, Melena D Bellin1.   

Abstract

Mesh：

Year:  2015        PMID： 26239608     DOI： 10.1038/nrendo.2015.126

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  10 in total

Review 1.  State of the art of clinical islet transplantation and novel protocols of immunosuppression.

Authors:  A M James Shapiro
Journal:  Curr Diab Rep       Date:  2011-10       Impact factor: 4.810

Review 2.  Death and dysfunction of transplanted β-cells: lessons learned from type 2 diabetes?

Authors:  Kathryn J Potter; Clara Y Westwell-Roper; Agnieszka M Klimek-Abercrombie; Garth L Warnock; C Bruce Verchere
Journal:  Diabetes       Date:  2014-01       Impact factor: 9.461

3.  Reduced progression of diabetic microvascular complications with islet cell transplantation compared with intensive medical therapy.

Authors:  David M Thompson; Mark Meloche; Ziliang Ao; Breay Paty; Paul Keown; R Jean Shapiro; Stephen Ho; Dan Worsley; Michelle Fung; Graydon Meneilly; Iain Begg; Mohammed Al Mehthel; Joma Kondi; Claire Harris; Blake Fensom; Sharon E Kozak; Suet On Tong; Mary Trinh; Garth L Warnock
Journal:  Transplantation       Date:  2011-02-15       Impact factor: 4.939

4.  Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network.

Authors:  Sandrine Lablanche; Sophie Borot; Anne Wojtusciszyn; Francois Bayle; Rachel Tétaz; Lionel Badet; Charles Thivolet; Emmanuel Morelon; Luc Frimat; Alfred Penfornis; Laurence Kessler; Coralie Brault; Cyrille Colin; Igor Tauveron; Domenico Bosco; Thierry Berney; Pierre-Yves Benhamou
Journal:  Diabetes Care       Date:  2015-06-11       Impact factor: 19.112

Review 5.  Evidence-informed clinical practice recommendations for treatment of type 1 diabetes complicated by problematic hypoglycemia.

Authors:  Pratik Choudhary; Michael R Rickels; Peter A Senior; Marie-Christine Vantyghem; Paola Maffi; Thomas W Kay; Bart Keymeulen; Nobuya Inagaki; Frantisek Saudek; Roger Lehmann; Bernhard J Hering
Journal:  Diabetes Care       Date:  2015-06       Impact factor: 19.112

6.  Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes.

Authors:  M D Bellin; F B Barton; A Heitman; J V Harmon; R Kandaswamy; A N Balamurugan; D E R Sutherland; R Alejandro; B J Hering
Journal:  Am J Transplant       Date:  2012-04-11       Impact factor: 8.086

7.  Five-year follow-up after clinical islet transplantation.

Authors:  Edmond A Ryan; Breay W Paty; Peter A Senior; David Bigam; Eman Alfadhli; Norman M Kneteman; Jonathan R T Lakey; A M James Shapiro
Journal:  Diabetes       Date:  2005-07       Impact factor: 9.461

8.  Five-year follow-up of patients with type 1 diabetes transplanted with allogeneic islets: the UIC experience.

Authors:  Meirigeng Qi; Katie Kinzer; Kirstie K Danielson; Joan Martellotto; Barbara Barbaro; Yong Wang; James T Bui; Ron C Gaba; Grace Knuttinen; Raquel Garcia-Roca; Ivo Tzvetanov; Andrew Heitman; Maureen Davis; James J McGarrigle; Enrico Benedetti; Jose Oberholzer
Journal:  Acta Diabetol       Date:  2014-07-18       Impact factor: 4.280

9.  Primary graft function, metabolic control, and graft survival after islet transplantation.

Authors:  Marie-Christine Vantyghem; Julie Kerr-Conte; Laurent Arnalsteen; Geraldine Sergent; Frederique Defrance; Valery Gmyr; Nicole Declerck; Violeta Raverdy; Brigitte Vandewalle; Pascal Pigny; Christian Noel; Francois Pattou
Journal:  Diabetes Care       Date:  2009-08       Impact factor: 19.112

10.  Improvement in β-cell secretory capacity after human islet transplantation according to the CIT07 protocol.

Authors:  Michael R Rickels; Chengyang Liu; Richard D Shlansky-Goldberg; Scott A Soleimanpour; Kumar Vivek; Malek Kamoun; Zaw Min; Eileen Markmann; Maral Palangian; Cornelia Dalton-Bakes; Carissa Fuller; Allen J Chiou; Clyde F Barker; Eline T Luning Prak; Ali Naji
Journal:  Diabetes       Date:  2013-04-29       Impact factor: 9.461
  10 in total
  4 in total

1.  Involvement of a proapoptotic gene (BBC3) in islet injury mediated by cold preservation and rewarming.

Authors:  Keiko Omori; Eiji Kobayashi; Hirotake Komatsu; Jeffrey Rawson; Garima Agrawal; Mounika Parimi; Alina R Oancea; Luis Valiente; Kevin Ferreri; Ismail H Al-Abdullah; Fouad Kandeel; Masafumi Takahashi; Yoko Mullen
Journal:  Am J Physiol Endocrinol Metab       Date:  2016-04-26       Impact factor: 4.310

2.  Interleukin-35 mitigates the function of murine transplanted islet cells via regulation of Treg/Th17 ratio.

Authors:  Yin Zongyi; Zou Funian; Li Hao; Wang Xin; Cheng Ying; Zhang Jialin; Liu Yongfeng; Li Baifeng
Journal:  PLoS One       Date:  2017-12-13       Impact factor: 3.240

3.  Dendritic Cells Transduced with Single Immunoglobulin IL-1-Related Receptor Exhibit Immature Properties and Prolong Islet Allograft Survival.

Authors:  Zhicheng Xue; Xuzhi Zhang; Maogen Chen; Xinjun Lu; Ronghai Deng; Yi Ma
Journal:  Front Immunol       Date:  2017-11-30       Impact factor: 7.561

Review 4.  Stepwise Approach to Problematic Hypoglycemia in Korea: Educational, Technological, and Transplant Interventions.

Authors:  Sang Man Jin
Journal:  Endocrinol Metab (Seoul)       Date:  2017-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.